Skip to main content
. Author manuscript; available in PMC: 2014 Nov 24.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2
Methods RCT, 2-arm trial.
Participants Setting: Los Angeles hospital, USA, 1996-2000
120 women with diabetes.
Inclusion criteria: women with insulin dependent or other diabetes, gestational age 38 weeks (confirmed by ultrasound), not in labour, normal AFI (> 5 cm), normal FHR. Women compliant with hospital appointments and home glucose monitoring
Exclusion criteria: women with multiple pregnancies, ruptured membranes, vaginal bleeding, prior uterine surgery, active genital herpes, glaucoma, serious medical disease, parity > 5, fetal weight > 4500 g or < 2000 g
Interventions Study over 7 days.
Intervention group: single dose of vaginal misoprostol 25 mcg
Comparison group: placebo of similar appearance.
Both groups were observed for 4 hrs and if there were no signs of fetal distress of painful contractions women were sent home. Reviewed after 3-4 days. If labour had not started then intervention/placebo was repeated. At 7 days women not in labour were induced
Outcomes Additional induction agents required (oxytocin), mode of delivery, uterine hyperstimulation, neonatal condition at delivery
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Computer generated sequence.
Allocation concealment? Yes Coded drug boxes. Pharmacy prepared and distributed medication according to the randomisation schedule
Blinding?
Women
Yes Placebo controlled trial.
Blinding?
Clinical staff
Yes
Blinding?
Outcome assessor
Unclear Not clear when code revealed.
Incomplete outcome data addressed?
All outcomes
Unclear 120 women randomised and no loss to follow up was apparent but denominators in the data tables were not always clear
Free of other bias? Yes